Fluvastatin Sodium thoxyisoflavone GSK650394 (from day 0 to

GSK650394 (from day 0 to 6 postsurgery

TL13-112 shows chemically induced degradation of anaplastic lymphoma kinase (ALK)

4-Dihydro-1-methyl-7-[(6-methyl-3-pyridinyl)amino]-2-oxopyrimido[4

InChi: InChI=1S/C25H30N6O3/c1-16-14-33-11-9-30(16)23-20-7-8-21(18-5-4-6-19(13-18)24(32)26-3)27-22(20)28-25(29-23)31-10-12-34-15-17(31)2/h4-8

Passacantilli S

Fluvastatin Sodium thoxyisoflavone GSK650394 (from day 0 toFluvastatin sodium is an HMG CoA reductase inhibitor used to lower cholesterol and lipid levels. It may inhibit RhoA. It also prevents viral replication of hepatitis C, decreases platelet activation, scavenges hydroxyl radicals, induces cell cycle arrest and apoptosis in hepatocellular carcinoma cells, and improves left ventricular function and prevents fibrosis in cardiac distress models. Product information CAS Number: 93957 55 2 Molecular Weight: